Literature DB >> 11250240

ISATX247: a novel calcineurin inhibitor.

M D. Abel1, L J. Aspeslet, D G. Freitag, S Naicker, D J. Trepanier, N M. Kneteman, R T. Foster, R W. Yatscoff.   

Abstract

Entities:  

Year:  2001        PMID： 11250240     DOI： 10.1016/s1053-2498(00)00290-4

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

Review 1.  Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.

Authors:  Omid Veiseh; Forrest M Kievit; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Drug Deliv Rev       Date:  2011-02-02       Impact factor: 15.470

2.  LX211 (voclosporin) suppresses experimental uveitis and inhibits human T cells.

Authors:  Matthew A Cunningham; Bobbie Ann Austin; Zhuqing Li; Baoying Liu; Steven Yeh; Chi-Chao Chan; Eddy Anglade; Poonam Velagaleti; Robert B Nussenblatt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-08-15       Impact factor: 4.799

Review 3.  NFAT proteins: emerging roles in cancer progression.

Authors:  Maria Mancini; Alex Toker
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

4.  Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1.

Authors:  Takashi Kawahara; Eiji Kashiwagi; Hiroki Ide; Yi Li; Yichun Zheng; Yurina Miyamoto; George J Netto; Hitoshi Ishiguro; Hiroshi Miyamoto
Journal:  Oncotarget       Date:  2015-01-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.